Dr. Michael R. Galambos, MD

Dr. Galambos practices at Digestive Healthcare of Georgia Endoscopy Center Mountainside in Atlanta, Georgia.

Dr. Galambos' NPI, 1356345011, was assigned on June 10, 2005. Dr. Galambos graduated from Emory University School of Medicine in 1984. Dr. Galambos holds Georgia license 030064.

Dr. Galambos' primary practice is Digestive Healthcare of Georgia Endoscopy Center Mountainside, at 3280 Howell Mill NW Rd, Atlanta, GA 30327 in Fulton County. The practice phone is (404) 603-3543.

Dr. Galambos' primary practice is Digestive Healthcare of Georgia Endoscopy Center Mountainside in Atlanta, Georgia. Dr. Galambos is also affiliated with Piedmont Atlanta. The medical group on file is Digestive Healthcare of Georgia. Dmand AI also links Dr. Galambos to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galambos practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Galambos' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Galambos is licensed in Georgia.

CMS data shows 2,502 Medicare services from Dr. Galambos across 20 procedure codes in 2024, for 1,078 Medicare patients. Medicare paid $198,305 for them.

CMS counts 1,078 Medicare patients who saw Dr. Galambos in 2024. The largest group is 65 to 74, with 536 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Galambos' median patient age at 68, with 56% women.

In 2024, Dr. Galambos wrote 2,388 Medicare Part D claims for 809 patients. 86% of them were for generic drugs. CMS names the drug for 2,084 of them, across 45 drugs with 11 or more claims each, at $775,943 in total drug cost. In 2023, CMS named 2,179 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Galambos for performance year 2024, reported through an alternative payment model (APM). Dr. Galambos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Galambos as offering telehealth. CMS counts 272 procedures of colonoscopy by Dr. Galambos, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Galambos, published from 2022 to 2023. The most frequent topics are Alkaline Phosphatase, Liver Cirrhosis, Biliary and Ursodeoxycholic Acid. Dr. Galambos' most frequent co-authors are Christopher L. Bowlus, MD, Aparna Goel, MD and Cynthia Levy, MD.

Dmand AI links Dr. Galambos to 11 clinical trials, 2 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Colitis, Ulcerative, Colitis and Crohn Disease. Eli Lilly and Company sponsors the most, 7. Open Payments lists research payments to Dr. Galambos that name 7 trials.

CMS Open Payments shows 449 general payments to Dr. Galambos from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Abbvie Inc. paid the most, $2,467. It also lists 18 research payments totaling $61,007 from 2017 to 2023, naming 7 clinical trials.

Dr. Galambos graduated from Emory University School of Medicine in 1984.